Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Centro Nacional de Epidemiología
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Epidemiología (26)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile
Open Forum Infectious Diseases, Vol. 11, Núm. 4
-
Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes
Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802
2023
-
Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 8
-
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47
-
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47
2022
-
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022
Emerging Infectious Diseases, Vol. 28, Núm. 9, pp. 1847-1851
-
Maternal Mortality in Africa: Regional Trends (2000–2017)
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 20
2021
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 26, Núm. 29
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
-
Energy intake, macronutrient profile and food sources of spanish children aged one to <10 years—results from the esnupi study
Nutrients, Vol. 12, Núm. 4, pp. 1-26
2019
2018
-
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients
Parkinsonism and Related Disorders, Vol. 52, pp. 83-89
-
Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire
npj Parkinson's Disease, Vol. 4, Núm. 1
2017
-
Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study)
Parkinson's Disease, Vol. 2017
-
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration
Movement Disorders Clinical Practice, Vol. 4, Núm. 4, pp. 536-544
-
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season
Eurosurveillance, Vol. 22, Núm. 41
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression [BMC Neurol. 16, (2015), 26] DOI: 10.1186/s12883-016-0548-9
BMC Neurology